Trial Profile
Effect of Romiplostim in children with severe chronic immune Thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2019
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary) ; Eltrombopag
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 21 Apr 2015 New trial record